FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   PreferencesPreferences   Log in to check your private messagesLog in to check your private messages   Log inLog in 
Forum index » Medicine forums » cardiology
Morphine for chest pain increases death risk
Post new topic   Reply to topic Page 1 of 1 [1 Post] View previous topic :: View next topic
Author Message
Roman Bystrianyk
medicine forum Guru


Joined: 02 May 2005
Posts: 454

PostPosted: Fri May 06, 2005 1:57 pm    Post subject: Morphine for chest pain increases death risk Reply with quote

"Morphine for chest pain increases death risk", Medical News Today, May
6, 2005,
Link: http://www.medicalnewstoday.com/medicalnews.php?newsid=23939

While patients hospitalized for a heart attack have long been treated
with morphine to relieve chest pain, an analysis by researchers from
the Duke Clinical Research Institute has shown that these patients have
almost a 50 percent higher risk of dying.

The researchers call for a randomized clinical trial to confirm their
analysis. Meanwhile, they advise cardiologists to begin treatment with
sufficient doses of nitroglycerin to relieve pain before resorting to
morphine.

In their analysis of the clinical data and outcomes of more than 57,000
high-risk heart attack patients -- 29.8 percent of whom received
morphine within the first 24 hours of hospitalization -- the
researchers found that those who received morphine had a 6.8 percent
death rate, compared to 3.8 percent for those receiving nitroglycerin.
The increase in mortality persisted even after adjustment for the
patients' baseline clinical risk.

The results of the Duke were published as a fast-track article in the
American Heart Journal.

"The results of this analysis raise serious concerns about the safety
of the routine use of morphine in this group of heart patients," said
Duke cardiologist Trip Meine, M.D., the study's lead author. "Since
randomized clinical trials evaluating the safety or effectiveness of
morphine for these patients have not been conducted, official
guidelines for its use are based solely on expert conjecture. Given the
adverse outcomes associated with morphine use found in our analysis, a
randomized clinical trial is in order."

Morphine was first used to relieve the chest pain associated with heart
attacks in 1912 and has been used regularly ever since. Nitroglycerin
has been used for more than 130 years for the relief of chest pain,
also known as unstable angina. It works by relaxing blood vessels and
allowing blood flow to increase.

"Nitroglycerin has a physiological effect that may, at least
temporarily, influence the underlying ischemia," Meine said. "Morphine,
on the other hand, doesn't do anything about what is actually causing
the pain. It just masks it, and may, in fact, make the underlying
disease worse.

"Morphine has the well-known and potentially harmful side effects of
depressing respiration, reducing blood pressure and slowing heart
rate," he continued. "These side effects could explain the worse
outcomes in patients whose heart function has already been compromised
by disease."

For their analysis, the researchers consulted the nationwide quality
improvement initiative named CRUSADE (Can Rapid Risk Stratification of
Unstable Angina Patients Suppress Adverse Outcomes with Early
Implementation of the American College of Cardiology and AHA
Guidelines) The registry continually collects data from more than 400
hospitals on outcomes and on the use of proven drugs and procedures
used to restore blood flow to the heart.

Quote:
From this registry, the researchers identified 57,039 high-risk
patients with non-ST-segment elevation myocardial infarction

(non-STEMI), a categorization of heart attack based on
electrocardiogram (ECG) readings. These patients typically arrive at
emergency rooms with chest pain, but often will not have telltale signs
of a heart attack on the initial ECG. They might be diagnosed with a
heart attack only when the results of the blood tests are reported a
few hours later.

The researchers found that patients who were given morphine had 48
percent higher risk of dying and 34 percent higher risk of suffering
another heart attack while in the hospital.

"This increase in mortality was present in every subgroup of patients
we studied," Meine said. "What we found interesting was that patients
given morphine were more likely to receive evidence-based medicine,
were more likely to be treated by a cardiologist and were more likely
to receive an invasive cardiac procedure."

Meine recommended that physicians with hospitalized heart attack
patients should begin with nitroglycerin therapy to control pain.

"Our recommendation is that patients should receive the full dose of
nitroglycerin," he said. "Based on our analysis, morphine should be the
last resort after else has been tried."

While patients with acute STEMI are at higher risk of dying within 30
days of their hospital stay, patients with non-STEMI actually have a
higher risk of dying six months and one year after initial hospital
presentation. It is estimated that about 1.3 million Americans are
hospitalized each year with non-STEMI.

CRUSADE continuously gathers data from participating U.S. hospitals on
treatments for patients with non-STEMI and provides quarterly feedback
to hospitals with the ultimate goal of improving adherence to the
ACC/AHA treatment guidelines and patient outcomes.

The CRUSADE registry is funded by Millennium Pharmaceuticals,
Cambridge, Mass., and Schering Corp, Kenilworth, N.J. Bristol-Meyers
Squibb/Sanofi Pharmaceuticals Partnership, NY, provided an unrestricted
grant in support of CRUSADE.

Contact: Richard Merritt Merri006@mc.duke.edu 919-684-4148 Duke
University Medical Center http://www.dukemednews.org
Back to top
Google

Back to top
Display posts from previous:   
Post new topic   Reply to topic Page 1 of 1 [1 Post] View previous topic :: View next topic
The time now is Sat Nov 22, 2008 3:58 am | All times are GMT
Forum index » Medicine forums » cardiology
Jump to:  

Similar Topics
Topic Author Forum Replies Last Post
No new posts Combining antioxidants with a severe ... ironjustice@aol.com cardiology 0 Tue Jul 11, 2006 6:10 pm
No new posts Genetic variants,insecticides, nerve ... eml cardiology 0 Sun Jul 09, 2006 4:04 pm
No new posts Common beta-agonist inhalers more tha... William Wagner cardiology 2 Sat Jul 08, 2006 10:25 am
No new posts Vascular disease risk factors may pre... listener cardiology 2 Fri Jul 07, 2006 12:15 pm
No new posts post adult strabismus pain Penelope$ vision 2 Thu Jul 06, 2006 11:14 pm

Web Hosting by Safehosting | Mortgage Calculator | Car Loan | Tesco | Mobile Phone
Copyright © 2004-2005 DeniX Solutions SRL
Other DeniX Solutions sites: electronics forum, Science forum Unix/Linux blog Unix/Linux documentation Unix/Linux forums


Powered by phpBB © 2001, 2005 phpBB Group
[ Time: 0.1541s ][ Queries: 16 (0.0807s) ][ GZIP on - Debug on ]